The present investigation showed that linagliptin attenuate palmitate-induced β-secreatse activity and Aβ generation, implying that DPP-4 could take part in regulating p-ser307IRS-1 and p-PI3K, and mediate the development of AD. This evidence concerns the gene DPP4 and Alzheimer disease.